The Ledger
Community Health Systems has until Monday to pull in holders of $1.24 billion of junior debt, and Fitch has already rated the swap as a default. The Franklin, Tennessee hospital operator launched an offer on November 9 to swap its 6.875% junior-priority secured notes due 2029 for new 10.25% senior secured notes due 2035, per the Business Wire release. Holders who tender by 5 p.m. New York time on November 23 get $1,000 of new notes per $1,000 tendered, including a $30 early premium. Later tenders through December 10 get $970. Holders of about 52% of the old notes, roughly $643.7 million, agreed to tender and to strip the old notes’ covenants. Fitch cut CHS to “C” from “CCC+” on November 17 because it treats the swap as a distressed debt exchange, and expects to move to “restricted default” when it closes, then re-rate, as reported by Becker’s Hospital Review (we could not open Fitch’s own release or the Becker’s page). Becker’s also reports Fitch expects leverage of 8.5 times EBITDA by the end of 2026, up from 7.7 times. Who it hits: noteholders, vendors and the communities served by 59 hospitals. The so-what: the swap pushes maturities out, adds coupon cost and leaves principal unchanged. Confidence: High on the offer terms (company release), Med on Fitch’s details (trade press only).
The numbers behind the swap: CHS lost $86 million in the third quarter as divestitures shrank the company by a tenth. In its October 28 earnings release filed with the SEC, CHS reported third-quarter net operating revenues of $2.757 billion, down 10.7% from $3.087 billion, and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of $280 million, down 25.5% from $376 million, a margin of 10.2% against 12.2%. Same-store revenue rose 3.8%, so most of the revenue drop is hospitals sold. The company went from 70 hospitals a year earlier to 60 at September 30 and 59 by October 28, and cash fell to $155 million from $260 million at December 31, 2025. The chief executive said payer mix and acuity “did not develop as expected.” Who it hits: operators and acquirers eyeing the next CHS hospital sale, since divestitures are the company’s main deleveraging tool. We could not read the guidance tables in the filing, so we are not repeating guidance figures. Confidence: High.
Labcorp is building out a fifth continent for drug-trial lab work, through a collaboration with Brazil’s Grupo Fleury rather than an acquisition. Labcorp announced on November 17 that it will add dedicated kit assembly and, later, laboratory operations for clinical trials in Brazil with Fleury, one of that country’s large diagnostic groups, per a Labcorp press release distributed by wire. Labcorp says its central lab network already spans four continents. No financial terms were disclosed, and one Portuguese-language report puts local kit assembly in early 2027. Who it hits: trial sponsors who currently ship Brazilian samples to U.S. labs, and independent lab competitors. The so-what: the clinical-trial side of the lab business is expanding by partnership, which needs less capital than a purchase. Confidence: Med, since the release came to us through a wire reprint.
Two Pennsylvania and Illinois hospital bankruptcies now have dates that matter. Redeemer Health, the Pennsylvania system that filed Chapter 11 on November 1 to sell or close 239-bed Holy Redeemer Hospital, has a final hearing on use of cash collateral set for December 14 after an interim order on November 9, per a Bondoro case summary and the Philadelphia Inquirer. Roseland Community Hospital in Chicago, which filed November 4 in the Northern District of Illinois with estimated assets and liabilities of $10 million to $50 million each, says it will file a reorganization plan within 120 days, which the Medical Daily report places in early March 2027. We covered both filings earlier this month; nothing new has been posted beyond these calendar dates. Who it hits: bondholders, trade creditors and any buyer weighing Holy Redeemer. Confidence: Med, we read summaries rather than the court dockets.
A note on today’s scan: we searched for insurer and hospital-operator filings, rating actions, closures, layoffs and deals from the last 48 hours. We could not verify any large-insurer earnings 8-K dated today. Becker’s and Fierce Healthcare blocked our reader, so hospital M&A roundups and layoff trackers were not opened, and we report no health-system layoffs because we could not confirm any with a date. Frontier scan (air medical and ground ambulance) found no November 2026 deal or filing we could confirm.
THE DEAL SHEET
| Target | Acquirer/Investor | Vertical | Value | Source |
|---|---|---|---|---|
| $1.24 billion of 6.875% junior-priority notes due 2029 (debt exchange, not an acquisition) | Community Health Systems noteholders, 52% pre-committed | Hospital operator capital structure | $1.244 billion of old notes for 10.25% senior secured notes due 2035; early deadline November 23, expiry December 10 | Business Wire release |
| Parkview Health nonemergent outreach laboratory services | Labcorp | Clinical laboratory | Not disclosed; unverified, per a Becker’s headline only, primary release not found | Becker’s Hospital Review |
No other new transactions spotted in the last 24 hours that we could confirm at a primary source.
Free. One email a day at 6pm your time, or one summary every Friday. Switch or stop anytime.